Jayant Chivate, MD
Payments from drug & device makers
Across 50 payments — averaging $25.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$358
- Tactile Systems Technology Inc$150
- Urgo Medical North America, LLC$126
- AbbVie$121
- KCI USA, Inc.$74
- Solventum Corporation$69
- plus $370 from 13 others
What the payments were for
- Food & beverage$1,268100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 12 | $358 |
| Tactile Systems Technology Inc | 7 | $150 |
| Urgo Medical North America, LLC | 4 | $126 |
| AbbVie | 3 | $121 |
| KCI USA, Inc. | 4 | $74 |
| Solventum Corporation | 2 | $69 |
| Paratek Pharmaceuticals, Inc. | 3 | $60 |
| Smith+Nephew | 2 | $55 |
| Bioventus LLC | 1 | $44 |
| Mimedx Group, Inc. | 2 | $43 |
| Lifenet Health | 1 | $26 |
| Advanced Oxygen Therapy Inc. | 2 | $23 |
| Hartmann USA, Inc. | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $20 |
| Kerecis Limited | 1 | $19 |
| Reapplix Inc. | 1 | $19 |
| Inari Medical, Inc. | 1 | $15 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $14 |
| Pfizer | 1 | $11 |
How this compares
$1,268 in reported general payments places this provider in the 50th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 25 | $1,219 |
| Doxycycline Hyclate | 58 | $398 |
| Clindamycin Hcl | 24 | $210 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $171 |
| Triamcinolone Acetonide | 17 | $118 |
| Ciprofloxacin Hcl | 14 | $41 |
Paid to pharmacies, not to this prescriber.
Other surgery in Sayre
- Giorgos KarakousisPhiladelphia$8.8M
- James MarkmannPhiladelphia$1.8M
- John MiuraPhiladelphia$1.3M
- Martin WijkstromPittsburgh$1.3M
- Andy KiserPittsburgh$1.1M
- Blair JobePittsburgh$827K
- Glenn SteeleDanville$698K
- Olwadamilola FayanjuPhiladelphia$668K
- Maher El ChaarAllentown$667K
- George EidPittsburgh$623K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.